Guideline

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy

Michelle A. Moorhouse, Sergio Carmona, Natasha Davies, Sipho Dlamini, Cloete van Vuuren, Thandekile Manzini, Moeketsi Mathe, Yunus Moosa, Jennifer Nash, Jeremy Nel, Yoliswa Pakade, Joana Woods, Gert van Zyl, Francesca Conradie, Francois Venter, Graeme Meintjes
Southern African Journal of HIV Medicine | Vol 19, No 1 | a917 | DOI: https://doi.org/10.4102/sajhivmed.v19i1.917 | © 2018 Michelle A. Moorhouse | This work is licensed under CC Attribution 4.0
Submitted: 20 September 2018 | Published: 17 October 2018

About the author(s)

Michelle A. Moorhouse, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Sergio Carmona, National Health Laboratory Services, South Africa
Natasha Davies, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Sipho Dlamini, Department of Medicine, University of Cape Town, South Africa
Cloete van Vuuren, Southern African HIV Clinicians Society, South Africa
Thandekile Manzini, Southern African HIV Clinicians Society, South Africa
Moeketsi Mathe, Private Practice, Vereeniging, South Africa
Yunus Moosa, Department of Infectious Diseases, University of KwaZulu-Natal, South Africa
Jennifer Nash, Southern African HIV Clinicians Society, South Africa
Jeremy Nel, Southern African HIV Clinicians Society, South Africa
Yoliswa Pakade, Southern African HIV Clinicians Society, South Africa
Joana Woods, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Gert van Zyl, Southern African HIV Clinicians Society, South Africa
Francesca Conradie, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Francois Venter, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Graeme Meintjes, Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa


Share this article

Bookmark and Share

Abstract

No abstract available.

 

 


Keywords

No related keywords in the metadata.

Metrics

Total abstract views: 3996
Total article views: 4171

 

Crossref Citations

1. Dapivirine vaginal ring forHIVprevention: modelling health outcomes, drug resistance and cost‐effectiveness
Robert Glaubius, Yajun Ding, Kerri J Penrose, Greg Hood, Erik Engquist, John W Mellors, Urvi M Parikh, Ume L Abbas
Journal of the International AIDS Society  vol: 22  issue: 5  first page: e25282  year: 2019  
doi: 10.1002/jia2.25282